Get the Stockscreener App
1.02
0.97%
-0.01
After Hours:
1.01
-0.01
-0.98%
Curis Inc stock is traded at $1.02, with a volume of 143.35K.
It is down -0.97% in the last 24 hours and up +12.01% over the past month.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
See More
Previous Close:
$1.03
Open:
$1.06
24h Volume:
143.35K
Relative Volume:
0.31
Market Cap:
$14.01M
Revenue:
$11.65M
Net Income/Loss:
$-36.56M
P/E Ratio:
-0.2774
EPS:
-3.677
Net Cash Flow:
$-30.09M
1W Performance:
-8.11%
1M Performance:
+12.01%
6M Performance:
-39.29%
1Y Performance:
-65.66%
1-Day Range:
$1.00
$1.11
1-Week Range:
$0.95
$1.14
52-Week Range:
$0.771
$3.18
Curis Inc Stock (CRIS) Company Profile
Name
Curis Inc
Sector
Industry
Phone
617-503-6500
Address
128 SPRING STREET, LEXINGTON, MA
Compare CRIS vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CRIS
Curis Inc
|
1.02 | 14.15M | 11.65M | -36.56M | -30.09M | -3.677 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.82 | 121.40B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
764.93 | 83.25B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
728.11 | 46.39B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.51 | 43.41B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
292.94 | 33.09B | 5.36B | 287.73M | 924.18M | 2.5229 |
Curis Inc Stock (CRIS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-19-25 | Resumed | H.C. Wainwright | Buy |
| Nov-17-23 | Initiated | Truist | Buy |
| Apr-04-22 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Oct-13-21 | Initiated | Raymond James | Outperform |
| Mar-25-21 | Initiated | B. Riley Securities | Buy |
| Jul-29-20 | Initiated | Laidlaw | Buy |
| Jul-17-20 | Initiated | Cantor Fitzgerald | Overweight |
| Oct-24-17 | Initiated | Guggenheim | Buy |
| Mar-02-16 | Initiated | Sun Trust Rbsn Humphrey | Buy |
| Nov-09-15 | Reiterated | ROTH Capital | Buy |
| Aug-11-15 | Initiated | FBR Capital | Outperform |
| Jan-22-15 | Reiterated | Oppenheimer | Outperform |
| Jan-21-15 | Reiterated | ROTH Capital | Buy |
| May-09-14 | Reiterated | Oppenheimer | Outperform |
| Oct-02-13 | Initiated | Robert W. Baird | Outperform |
| Sep-30-13 | Initiated | Chardan Capital Markets | Buy |
| Nov-14-12 | Initiated | Stifel Nicolaus | Hold |
| Jan-31-12 | Reiterated | Brean Murray | Buy |
| Jan-31-12 | Reiterated | Summer Street Research | Buy |
| Dec-09-11 | Initiated | Oppenheimer | Outperform |
| Oct-06-11 | Initiated | Summer Street Research | Buy |
| Sep-22-11 | Initiated | MLV Capital | Buy |
| Mar-21-11 | Reiterated | Brean Murray | Buy |
| Feb-26-10 | Reiterated | Roth Capital | Buy |
| Jan-07-10 | Initiated | Roth Capital | Buy |
View All
Curis Inc Stock (CRIS) Latest News
Head-To-Head Analysis: eXoZymes (NASDAQ:EXOZ) & Curis (NASDAQ:CRIS) - Defense World
Bull Run: Will Curis Inc benefit from AI trendsMarket Risk Summary & Reliable Intraday Trade Plans - baoquankhu1.vn
CRIS Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Is Curis Inc. a speculative investmentJuly 2025 Rallies & Low Volatility Stock Recommendations - mfd.ru
Aug Chart Watch: Is Curis Inc a potential multi baggerJuly 2025 EndofMonth & Breakout Confirmation Trade Signals - baoquankhu1.vn
Can Curis Inc. stock hit analyst price targetsMarket Activity Recap & Weekly Watchlist for Hot Stocks - mfd.ru
Large share increase and PIPE-driven dilution on ballot at Curis (NASDAQ: CRIS) - Stock Titan
Armistice Capital (CRIS) reports 1.34M shares, 9.99% ownership - Stock Titan
Trading Recap: What are analysts price targets for Curis Inc2025 Buyback Activity & Real-Time Buy Zone Alerts - baoquankhu1.vn
What’s the MACD signal for Curis Inc.July 2025 Retail & Consistent Profit Trading Strategies - mfd.ru
Curis (CRIS) Moves to Offer Over 107 Million Shares of Common St - GuruFocus
Curis Provides Third Quarter 2024 Business Update - GuruFocus
Curis, Inc. (CRIS) stock news today: Live updates - Bitget
According to the latest filing from the U.S. Securities and Exchange Commission (SEC), some shareholders of the biopharmaceutical company Curis Inc plan to resell their ordinary shares in the open market in an irregular and batch-by-batch manner. - Bitget
What are Curis Inc.’s recent SEC filings showing2025 Key Lessons & Real-Time Buy Signal Notifications - mfd.ru
Is Curis Inc. (CUS0) stock positioned for secular growthLayoff News & Low Drawdown Trading Strategies - mfd.ru
How The Narrative Around Curis (CRIS) Is Shifting As Assumptions Change Not The US$14 Target - Yahoo Finance
Curis regains compliance with Nasdaq listing standards, enters monitoring period - Investing.com
Curis Regains Nasdaq Compliance, Remains Under Monitoring Period - TipRanks
Curis (CRIS) targets major share hike to unlock PIPE and new 2026 equity plan - Stock Titan
Curis Advances Clinical Pipeline with Focus on Leukemia Treatments - AD HOC NEWS
Buyout Rumor: Is Curis Inc a potential multi bagger2025 Market WrapUp & Weekly Breakout Opportunity Watchlist - baoquankhu1.vn
Curis (CRIS) to Release Earnings on Wednesday - Defense World
Panic Selling: Is Curis Inc exposed to political riskQuarterly Portfolio Summary & High Accuracy Swing Trade Signals - baoquankhu1.vn
Aug Drivers: Is Curis Inc stock a value trap2025 Technical Patterns & Smart Allocation Stock Tips - baoquankhu1.vn
Is Curis Inc. stock a value trapJuly 2025 Chart Watch & High Accuracy Swing Trade Signals - mfd.ru
Curis Targets BTKi-Exposed CLL With New Emavusertib Combo Trial: What Investors Should Watch - TipRanks
Bond Watch: Is Curis Inc exposed to political risk2025 Macro Impact & Risk Adjusted Buy and Sell Alerts - baoquankhu1.vn
Curis shares jump after lining up up to $80.8m in private placement financing - MSN
Curis Announces Closing of Private Placement Totaling up to $80.8 Million in Gross Proceeds - marketscreener.com
Looking At The Narrative For Curis CRIS After Fresh Funding And Fair Value Reset - Yahoo Finance
Curis closes private placement for up to $80.8 million in funding - Investing.com Nigeria
Curis announces closing of private placement totaling up to $80.8 million in gross proceeds - marketscreener.com
Stock Market Recap: Can Curis Inc. stock beat analyst upgradesQuarterly Profit Review & Daily Chart Pattern Signals - Улправда
Is Curis Inc. (CUS0) stock a top dividend aristocrat candidateJuly 2025 Update & Free Risk Controlled Daily Trade Plans - Улправда
Curis prices private placement of $80.8M - MSN
Volume Recap: Can Curis Inc. stock maintain growth trajectoryEntry Point & Consistent Income Trade Recommendations - ulpravda.ru
Curis (NASDAQ: CRIS) sets PIPE financing with warrants and targets 2027 cash runway - Stock Titan
Curis Announces PIPE Financing and Strategic Capital Strengthening - TipRanks
Curis Signs Multiple Material Agreements - TradingView — Track All Markets
Curis announces $80.8 million private placement to fund drug development By Investing.com - Investing.com Nigeria
Curis Inc: Can This Beaten-Down Cancer Stock Still Surprise The Market? - AD HOC NEWS
Aug Breakouts: Can Curis Inc stock maintain growth trajectoryDividend Hike & Daily Profit Maximizing Trade Tips - moha.gov.vn
Curis, Inc. announced that it expects to receive $20.195 million in funding - marketscreener.com
Curis announces $80.8M private placement - TipRanks
Crude Oil Down 2%; ISM Services PMI Surges In December - Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Curis (CRIS) Secures PIPE Deal for Up to $80.8M - GuruFocus
Curis announces pricing of private placement totaling up to $80.8 million in gross proceeds - marketscreener.com
Curis stock soars after securing $80.8 million private placement deal By Investing.com - Investing.com South Africa
Curis stock soars after securing $80.8 million private placement deal - Investing.com India
Curis Inc Stock (CRIS) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.69%
0.68%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):